BioVie Inc. has entered into an agreement to sell up to 1,146,000 shares of its Class A common stock at $2.83 per share, expecting to raise approximately $3.24 million before expenses. The offering is set to close on October 29, 2024, and includes a warrant for the placement agent to purchase additional shares.